loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2014_293___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Phalanx Labs

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PHALANX LABS PRIVATE LIMITED Hyderabad IN (1)

    filter

    01 Sumatriptan succinate (1)

    filter

    01 India (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    PHALANX LABS PRIVATE LIMITED Hydera...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Sumatriptan succinate

      PDF Supplier PDF
      URL Supplier Web Content
      R0-CEP 2014-293 - Rev 01
      Withdrawn by Holder
      Chemical
      2020-02-20
      2021-03-17
      1573
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-293 - Rev 01 of Phalanx Labs Private Limited Hyderabad In

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-293 - Rev 01 of Phalanx Labs Private Limited Hyderabad In 1

      20

      Phalanx Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company.

      One of their significant offerings is Sumatriptan succinate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2014-293 - Rev 01

      This Chemical Type CEP, issued on February 20, 2020, remains in force until March 17, 2021, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1573 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY